319 related articles for article (PubMed ID: 22546326)
1. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.
Ambrosi A; Wahren-Herlenius M
Arthritis Res Ther; 2012 Apr; 14(2):208. PubMed ID: 22546326
[TBL] [Abstract][Full Text] [Related]
2. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
[TBL] [Abstract][Full Text] [Related]
3. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of congenital heart block.
Ambrosi A; Sonesson SE; Wahren-Herlenius M
Exp Cell Res; 2014 Jul; 325(1):2-9. PubMed ID: 24434353
[TBL] [Abstract][Full Text] [Related]
5. Molecular and ionic basis of congenital complete heart block.
Boutjdir M
Trends Cardiovasc Med; 2000 Apr; 10(3):114-22. PubMed ID: 11427998
[TBL] [Abstract][Full Text] [Related]
6. Interferons and innate immune activation in autoimmune congenital heart block.
Ambrosi A; Thorlacius GE; Sonesson SE; Wahren-Herlenius M
Scand J Immunol; 2021 Jan; 93(1):e12995. PubMed ID: 33188653
[TBL] [Abstract][Full Text] [Related]
7. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
8. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.
Strandberg LS; Cui X; Rath A; Liu J; Silverman ED; Liu X; Siragam V; Ackerley C; Su BB; Yan JY; Capecchi M; Biavati L; Accorroni A; Yuen W; Quattrone F; Lung K; Jaeggi ET; Backx PH; Deber CM; Hamilton RM
PLoS One; 2013; 8(9):e72668. PubMed ID: 24039792
[TBL] [Abstract][Full Text] [Related]
9. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
Ayed K; Gorgi Y; Sfar I; Khrouf M
Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
[TBL] [Abstract][Full Text] [Related]
11. Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block.
Buyon JP; Clancy RM
Lupus; 2008 Feb; 17(2):86-90. PubMed ID: 18250129
[TBL] [Abstract][Full Text] [Related]
12. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
[TBL] [Abstract][Full Text] [Related]
13. Neonatal lupus: bedside to bench and back.
Buyon JP
Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
[TBL] [Abstract][Full Text] [Related]
14. Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.
Hedlund M; Thorlacius GE; Ivanchenko M; Ottosson V; Kyriakidis N; Lagnefeldt L; Tingström J; Sirsjö A; Bengtsson AA; Aronsson E; Gemzell-Danielsson K; Ronnblom L; Bergman G; Espinosa A; Sonesson SE; Eloranta ML; Wahren-Herlenius M
RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958275
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
[TBL] [Abstract][Full Text] [Related]
16. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
Friedman DM; Rupel A; Glickstein J; Buyon JP
Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
[TBL] [Abstract][Full Text] [Related]
17. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model.
Boutjdir M; Chen L; Zhang ZH; Tseng CE; El-Sherif N; Buyon JP
Pediatr Res; 1998 Jul; 44(1):11-9. PubMed ID: 9667364
[TBL] [Abstract][Full Text] [Related]
18. Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.
Hoxha A; Ruffatti A; Ambrosi A; Ottosson V; Hedlund M; Ottosson L; Anandapadamanaban M; Sunnerhagen M; Sonesson SE; Wahren-Herlenius M
Clin Exp Immunol; 2016 Dec; 186(3):284-291. PubMed ID: 27548532
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block.
Boutjdir M; Chen L; Zhang ZH; Tseng CE; DiDonato F; Rashbaum W; Morris A; el-Sherif N; Buyon JP
Circ Res; 1997 Mar; 80(3):354-62. PubMed ID: 9048655
[TBL] [Abstract][Full Text] [Related]
20. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
Sonesson SE; Ambrosi A; Wahren-Herlenius M
Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
